TickerFactsScreenerDevelopers

Celldex Therapeutics, Inc. (CLDX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $44.26M2009: $57.00M2010: $21.29M2011: $11.90M2012: $24.90M2013: $169.40M2014: $28.02M2015: $72.11M2016: $42.46M2017: $40.29M2018: $24.31M2019: $11.23M2020: $43.84M2021: $39.14M2022: $29.43M2023: $34.81M2024: $28.36M2025: $28.87M$28.87M
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$28.87M+1.8%
2024$28.36M-18.6%
2023$34.81M+18.3%
2022$29.43M-24.8%
2021$39.14M-10.7%
2020$43.84M+290.3%
2019$11.23M-53.8%
2018$24.31M-39.7%
2017$40.29M-5.1%
2016$42.46M-41.1%
2015$72.11M+157.3%
2014$28.02M-83.5%
2013$169.40M+580.4%
2012$24.90M+109.2%
2011$11.90M-44.1%
2010$21.29M-62.7%
2009$57.00M+28.8%
2008$44.26M—